Clearpoint Neuro Net Worth

Clearpoint Neuro Net Worth Analysis

Clearpoint Neuro Target Price Consensus

Clearpoint Neuro Target Price Projection

Clearpoint Neuro's current and average target prices are 13.38 and 17.00, respectively. The current price of Clearpoint Neuro is the price at which Clearpoint Neuro is currently trading. On the other hand, Clearpoint Neuro's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Clearpoint Neuro and the information provided on this page.

Know Clearpoint Neuro's Top Institutional Investors

Note, although Clearpoint Neuro's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Clearpoint Neuro's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 366.68 M.

Project Clearpoint Neuro's profitablity

The company has Profit Margin (PM) of (0.6) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.72) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.72.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Clearpoint Neuro's management efficiency

Clearpoint Neuro has return on total asset (ROA) of (0.3016) % which means that it has lost $0.3016 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8124) %, meaning that it created substantial loss on money invested by shareholders. Clearpoint Neuro's management efficiency ratios could be used to measure how well Clearpoint Neuro manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.51 in 2025. Return On Capital Employed is likely to drop to -0.72 in 2025. At this time, Clearpoint Neuro's Total Current Liabilities is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 1.6 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 24.6 M in 2025.

Clearpoint Neuro Corporate Filings

Clearpoint Neuro time-series forecasting models is one of many Clearpoint Neuro's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Clearpoint Neuro's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Clearpoint Neuro Earnings Estimation Breakdown

The calculation of Clearpoint Neuro's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Clearpoint Neuro is estimated to be -0.16 with the future projection ranging from a low of -0.19 to a high of -0.14. Please be aware that this consensus of annual earnings estimates for Clearpoint Neuro is based on EPS before non-recurring items and includes expenses related to employee stock options.

Clearpoint Neuro Earnings Projection Consensus

Clearpoint Neuro Earnings History

Earnings estimate consensus by Clearpoint Neuro analysts from Wall Street is used by the market to judge Clearpoint Neuro's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Clearpoint Neuro's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. Price Earnings To Growth Ratio is likely to gain to 1.04 in 2025, whereas Retained Earnings are likely to drop (200.9 M) in 2025. Common Stock Shares Outstanding is likely to gain to about 28.4 M in 2025, despite the fact that Net Loss is likely to grow to (14.1 M).

Hype Prediction Low Estimated High 8.11 13.27 18.43 Details

Intrinsic Valuation Low Real High 5.59 10.75 15.91 Details

Naive Forecast Low Next High 9.92 15.08 20.24 Details

3 Analysts Consensus Low Target High 15.47 17.00 18.87 Details

Note that many institutional investors and large investment bankers can move markets due to the volume of Clearpoint assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Clearpoint Neuro. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Clearpoint Neuro's stock price in the short term.

Clearpoint Neuro Earnings per Share Projection vs Actual

Actual Earning per Share of Clearpoint Neuro refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Clearpoint Neuro predict the company's earnings will be in the future. The higher the earnings per share of Clearpoint Neuro, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Clearpoint Neuro Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Clearpoint Neuro, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Clearpoint Neuro should always be considered in relation to other companies to make a more educated investment decision.

Clearpoint Quarterly Analyst Estimates and Surprise Metrics

Clearpoint Neuro Corporate Management

Additional Tools for Clearpoint Stock Analysis